1. Van de Klift M, de Laet CE, Coebergh JW, Hofman A, Pols HA. Bone mineral density and the risk of breast cancer: the Rotterdam Study. Bone. 2003. 32:211–216.
Article
2. Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev. 1993. 15:48–65.
Article
3. Dorgan JF, Longcope C, Stephenson HE, Falk RT, Miller R, Franz C, et al. Serum sex hormone levels are related to breast cancer risk in postmenopausal women. Environ Health Perspect. 997. 105:583–585.
Article
4. Thomas HV, Reeves GK, Key TJ. Endogenous estrogen and postmenopausal breast cancer: a quantitative review. Cancer Causes Control. 1997. 8:922–928.
5. Cauley JA, Gutai JP, Sandler RB, LaPorte RE, Kuller LH, Sashin D. The relationship of endogenous estrogen to bone density and bone area in normal postmenopausal women. Am J Epidemiol. 1986. 124:752–761.
Article
6. Buist DS, LaCroix AZ, Barlow WE, White E, Weiss NS. Bone mineral density and breast cancer risk in postmenopausal women. J Clin Epidemiol. 2001. 54:417–422.
Article
7. Cauley JA, Lucas FL, Kuller LH, Vogt MT, Browner WS, Cummings SR. Study of Osteoporotic Fractures Research Group. Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. JAMA. 1996. 276:1404–1408.
Article
8. Nguyen TV, Center JR, Eisman JA. Association between breast cancer and bone mineral density: the Dubbo Osteoporosis Epidemiology Study. Maturitas. 2000. 36:27–34.
Article
9. Zhang Y, Kiel DP, Kreger BE, Cupples LA, Ellison RC, Dorgan JF, et al. Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med. 1997. 336:611–617.
Article
10. Jo JM, Kim JS, Kim GS, Kim SW, Shin JW, Moon DH. Cross-calibration of Bone mineral density between two different dual X-ray absorptiometry systems: Hologic QDR 4500-A and Lunar EXPERT-XL. Korean J Nucl Med. 1999. 33:282–288.
11. Helzlsouer KJ, Alberg AJ, Bush TL, Longcope C, Gordon GB, Comstosck GW. A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev. 1994. 18:79–85.
12. Toniolo PG, Levitz M, Zelenuich-Jacquotte A, Banerjee S, Koenig SL, Shore RE. A prospective study of endogenous estrogens and breast cancer in post menopausal women. J Natl Cancer Inst. 1995. 87:190–197.
Article
13. Key T, Appleby P, Barnes I, Reeves G. Endogenous sex hormones and breast cancer in postmenopausal women:reanalysis of nine prospective studies. J Natl Cancer Inst. 2002. 94:606–616.
14. Ganry O, Baudoin C, Fardellone P, Peng J, Raverdy N. Bone mass density and risk of breast cancer and survival in older women. Eur J Epidemiol. 2004. 19:785–792.
Article
15. O'Brien K. High bone mass as a marker for breast cancer risk. Nutr Rev. 1997. 55:284–286.
16. Ganry O, Peng J, Dubreuil A. Is there a reduced risk of breast cancer among women with hip fractures? Eur J Epidemiol. 1999. 15:313–315.
17. Ganry O, Tramier B, Fardellone P, Raverdy N, Dubreuil A. High bone-mass density as a marker for breast cancer in post-menopausal women. Breast. 2001. 10:313–317.
Article
18. Nguyen TV, Center JR, Eisman JA. Association between breast cancer and bone mineral density: the Dubbo Osteoporosis Epidemiology Study. Maturitas. 2000. 36:27–34.
Article
19. Bruning PF, Bonfrer JM, van Noord PA, Hart AA, de Jong-Bakker M, Nooijen WJ. Insulin resistance and breast-cancer risk. Int J Cancer. 1992. 52:511–516.
Article
20. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet. 1998. 351:1393–1396.
Article
21. Langlois JA, Rosen CJ, Visser M, Hannan MT, Harris T, Wilson PW, et al. Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. J Clin Endocrinol Metab. 1998. 83:4257–4262.
Article
22. van Daele PL, Stolk RP, Burger H, Algra D, Grobbee DE, Hofman A, et al. Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam Study. Ann Intern Med. 1995. 122:409–414.
Article
23. Oh SY, Kang MJ, Moon WS, Choi HY. Correlation between Expression of Insulin-like Growth Factor-I Receptor and Clinicopathologic Prognostic Factors in Invasive Ductal Carcinoma of the Breast. J Korean Breast Cancer Soc. 2002. 5:118–124.
Article
24. Yee D, Lee AU. Crosstalk between the insalin-like growth factors and estrogens in breast Cancer. J Mammary Gland Bio 1 Neoplasia. 2000. 5:107–115.
25. Ziv E, Cauley J, Morin PA, Saiz R, Browner WS. Association between the T29°Ê polymorphism in the transforming growth factor beta1 gene and breast cancer among elderly white women. The Study of Osteoporotic Fractures. JAMA. 2001. 285:2859–2863.
Article
26. Yamada Y, Miyauchi A, Goto J, Takagi Y, Okuizumi H, Kanematsu M, et al. Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res. 1998. 13:1569–1576.
Article
27. Shin JH, Kim DY, Im GI, Kim CI, Song SH, Jeong HJ. Assessment of bone mineral density by dual energy x-ray absorptiometry in Korean postmenopausal women. J Korean Orthop Assoc. 1997. 32:593–599.
Article
28. Koh SK, Cho SH, Hwang YY, Moon H, Kim DS, Cho JL, et al. Spinal bone mineral density of normal and osteoporotic women in Korea? J Korean Med Sci. 1992. 7:136–140.
Article
29. Han IK, Park WK, Choi WW, Shin HH, Kim SW. A study on hormonal changes and bone densities in Korean menopausal women. J Kor Soc Endo. 1989. 4:21–28.
30. Song SH, Shim CG, Seo H. Change in bone mineral density according to aging in Korean women: Study of Using Quantitative Computerized Tomography. J Korean Orthop Assoc. 2000. 35:277–282.
Article